News
-
-
-
-
-
-
-
-
-
PRESS RELEASE
Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
Jaguar Health announces success of crofelemer powder for oral solution in treating infant patient with congenital sodium diarrhea. Plans for NDA in 2027 for MVID treatment -